Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: Failure of methylene blue treatment [2]

Haematologica

Volumn 86, Issue 6, 2001, Pages 659-660

  Karadsheh, N S ^a   Shaker, Q ^a   Ratroat, B ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

G6PD; Methemoglobinemia; Metoclopramide; NADH cytochrome b5 reductase

Indexed keywords

CYTOCHROME B5 REDUCTASE; METHYLENE BLUE; METOCLOPRAMIDE;

ADULT; BLOOD SAMPLING; CASE REPORT; CYANOSIS; DISEASE CLASSIFICATION; ENZYME ACTIVITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; KIDNEY DISEASE; LABORATORY DIAGNOSIS; LETTER; MALE; METHEMOGLOBINEMIA; NAUSEA; TREATMENT FAILURE;

ADULT; CYTOCHROME REDUCTASES; CYTOCHROME-B(5) REDUCTASE; DOPAMINE ANTAGONISTS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; JORDAN; MALE; METHEMOGLOBINEMIA; METHYLENE BLUE; METOCLOPRAMIDE; TREATMENT FAILURE;

EID: 0034950441     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Cytochrome b5 reductase deficiency and enzymatic hereditary methemoglobinemia
2. Methaemoglobinaemia
3. Metoclopramide-induced methemoglobinemia
4. A metoclopramide metabolite with a methemoglobinizing action
5. Metoclopramide-induced methemoglobinemia in an adult
6. Methaemoglobinaemia produced by metoclopramide in an adult
7. Failure of methylene blue treatment in toxic methemoglobinemia
8. La methemoglobinemie congenitale et recessive